Titanium Media App reported on July 25 that a national video and teleconference on drug supervision and management was held on the 25th. The meeting emphasized that it is necessary to deepen the special rectification of drug safety, promote the reform of drug supervision, improve the efficiency of drug supervision, effectively ensure the safety and effectiveness of the people's medication, support the high-quality development of the pharmaceutical industry, and take practical actions to welcome the victory of the 20th National Congress of the Communist Party of China. Jiao Hong, director of the State Food and Drug Administration, summarized the drug supervision work in the first half of the year and made specific arrangements for the work in the second half of the year, emphasizing efforts to "expand, consolidate, deepen and improve". First, make every effort to ensure the stability of the drug safety situation, promote the implementation of special drug safety rectification, focus on strengthening quality and safety supervision, and continue to improve the level of vaccine supervision. The second is to fully serve the overall situation of epidemic prevention and control, coordinate emergency approval and quality supervision, speed up the research and development of new coronavirus treatment drugs, and strengthen new coronavirus vaccine innovation services and quality supervision. Chain quality supervision. The third is to fully serve the overall situation of economic and social development, deepen the reform of the review and approval system, optimize the regulatory mechanism that is conducive to pharmaceutical innovation and industrial upgrading, promote the solution of the "stuck neck" problem of industrial innovation and development, promote the inheritance, innovation and development of traditional Chinese medicine, and deepen the "decentralization". "Service" reform, and guide the industry to achieve high-quality development with strong supervision. Fourth, make every effort to consolidate the foundation for system development, improve supervision capabilities, improve the regulatory and standard system, strengthen the technical support system, vigorously develop smart supervision and supervision science, deepen international cooperation, and further improve the scientific, legal, international and modern level of drug supervision. .
This article is reprinted from: https://readhub.cn/topic/8hWp4FsmAQu
This site is for inclusion only, and the copyright belongs to the original author.